证券代码：300253 证券简称：卫宁健康 公告编号：2025-059 债券代码：123104 债券简称：卫宁转债 卫宁健康科技集团股份有限公司 关于不向下修正卫宁转债转股价格的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、截至 2025 年 7 月 18 日下午收市，公司股票在连续 30 个交易 日中已有 15 个交易日的收盘价低于当期转股价格 17.31 元/股的 85% （即 14.71 元/股）的情形，已经触发"卫宁转债"转股价格向下修 正条款。 2、公司于 2025 年 7 月 18 日召开第六届董事会第十五次会议， 审议通过《关于不向下修正"卫宁转债"转股价格的议案》，决定本 次不向下修正"卫宁转债"转股价格，且自本次董事会审议通过次一 交易日起未来 3 个月内（即 2025 年 7 月 21 日至 2025 年 10 月 20 日）， 如再次触发"卫宁转债"转股价格的向下修正条件，亦不提出向下修 正方案。下一触发转股价格修正条件的期间从 2025 年 10 月 21 日重 新起算，若再次触发"卫宁转债"转股价格向下修正条件 ...

证券代码：300253 证券简称：卫宁健康 公告编号：2025-058 卫宁健康科技集团股份有限公司 第六届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特此公告。 卫宁健康科技集团股份有限公司 董 事 会 二〇二五年七月十八日 卫宁健康科技集团股份有限公司（以下简称"公司"）于 2025 年 7 月 18 日在公司会议室以现场和通讯相结合的表决方式召开了第 六届董事会第十五次会议。会议通知于 2025 年 7 月 15 日以专人送达 或电子邮件方式发出。会议应出席董事 7 人，实际出席董事 7 人。本 次董事会的召集和召开符合《中华人民共和国公司法》和《公司章程》 的规定。会议由董事长周炜主持，公司监事及高级管理人员列席了本 次董事会。经全体董事表决，形成决议如下： 会议以 5 票同意、0 票反对、0 票弃权的结果审议通过了《关于 不向下修正"卫宁转债"转股价格的议案》。 公司董事会决定本次不向下修正"卫宁转债"转股价格，同时自 本次董事会审议通过次一交易日起未来 3 个月内（即 2025 年 7 月 21 日至 2025 年 ...

Investment Rating - The report maintains a positive outlook on the computer industry for Q2 2025, indicating an expected improvement in performance [2][4]. Core Insights - The report predicts a gradual recovery in industry profits starting from Q2 2025, with revenue growth rates of 5% and 21% for Q4 2024 and Q1 2025 respectively, and net profit growth rates of -68% and 82% [4][5]. - A total of 55 tracked A-share and Hong Kong-listed computer companies are analyzed, with 13 companies expected to achieve over 50% net profit growth, representing 23.6% of the sample [4][5]. - The report identifies key investment targets across various segments, including AIGC, digital economy leaders, and data innovation [4][5]. Summary by Category Company Performance Predictions - Companies with over 50% net profit growth include: - Jinzheng Co. (4493%) - Zhongke Chuangda (333%) - Zhina Zhen (313%) - Kalait (265%) - Hengsheng Electronics (233%) [4][5][6]. - Companies with 30%-50% net profit growth include: - Dameng Data (48%) - Fanwei Network (39%) - New Point Software (38%) [4][5][6]. - Companies with 0%-30% net profit growth include: - Dongfang Caifu (27%) - Haiguang Information (27%) - Desai Xiwai (27%) [4][5][6]. - Companies with -30% to 0% net profit growth include: - Weining Health (-4%) - Nova Star Cloud (-11%) [4][5][6]. - Companies with less than -30% net profit growth include: - Qiming Star (-30%) - Top Point Software (-36%) [4][5][6]. Key Investment Targets - AIGC Segment: Jinshan Office, Wanxing Technology, Daotong Technology, Hongsoft Technology, and others [4]. - Digital Economy Leaders: Hikvision, Jinshan Office, Hengsheng Electronics, and others [4]. - Data Innovation: Haiguang Information, Ruantong Power, Suocheng Technology, and others [4]. - AIGC Computing Power: Langchao Information, Haiguang Information, and others [4].

Investment Rating - The report indicates a positive investment outlook for the AI healthcare industry, highlighting significant growth potential and increasing investment activity in the sector [3][10][46]. Core Insights - The AI healthcare sector is entering a new phase characterized by multi-modal integration and practical applications, driven by advancements in large models and generative AI [3][7]. - Clinical decision support and drug development are leading the commercialization efforts, while health management remains an area with untapped potential [3][14]. - The report emphasizes the importance of third-party vendors in reducing model hallucination rates and enhancing the reliability of AI applications in healthcare [3][18][21]. Summary by Sections AI Healthcare Trends - The industry is experiencing heightened investment interest and technological advancements, with major players accelerating their presence in the AI healthcare space [9][10][13]. - The integration of AI into clinical workflows is becoming standard, with AI-assisted diagnosis systems deployed in 89% of tertiary hospitals [8][14]. AI Healthcare Application Penetration - AI applications are diversifying across clinical diagnosis, drug development, health management, and AI for science (AI4S), with varying levels of maturity and market potential [30][31]. - The report identifies key areas of application, including intelligent clinical decision support, drug discovery, and personalized health management [36][39]. Key Companies in AI Clinical Diagnosis - Companies like Tempus AI and 嘉和美康 are leading in AI-assisted clinical diagnosis, focusing on electronic medical records and data-driven healthcare solutions [47][51]. - The report highlights the importance of data barriers and scenario positioning in determining the value of AI diagnostic tools [3][46]. Key Companies in AI Health Management - Companies such as 阿里健康 and 京东健康 are leveraging AI to enhance online healthcare services, with a focus on chronic disease management and personalized health plans [39][44]. - The report notes that the integration of insurance and healthcare services is crucial for the growth of AI health management solutions [39][44]. Key Companies in AI Drug Development - The report discusses the role of AI in accelerating drug development processes, with companies like Recursion and 晶泰控股 focusing on preclinical research and drug discovery [38][44]. - AI is expected to significantly reduce the time and cost associated with traditional drug development methods [38][44]. AI4S and Broader Applications - AI4S is identified as a growing field with applications in various scientific domains, including life sciences and materials science, although it faces longer conversion cycles [42][44]. - The report emphasizes the need for innovative approaches to data generation and modeling in AI4S applications [42][44].

Investment Rating - The report maintains a positive investment rating for the domestic computing power and AI application sectors, highlighting significant growth potential in these areas [6]. Core Insights - A new round of AI "arms race" has commenced globally, with the release of major models like Grok4 and Kimi K2 expected to significantly boost domestic computing power demand and application ecosystems [4][10]. - The report emphasizes the importance of focusing on domestic AI computing power, particularly in chip design, advanced wafer manufacturing, and liquid cooling technologies [4]. - Various AI application sectors are highlighted, including office automation, programming, terminal AI, ERP/CRM, judicial applications, financial/taxation services, education, healthcare, and customer service [4]. Summary by Sections Market Review - During the week of July 7-11, the CSI 300 index rose by 0.82%, the SME index increased by 0.73%, and the ChiNext index saw a rise of 2.36%. The computer sector (CITIC) experienced a growth of 3.37% [2]. Industry News - Notable company developments include Zhuoyi Information's plan to reduce its shareholding by up to 2,271,445 shares, representing no more than 1.88% of total shares [3]. - Wanjie Technology received nine invention patent certificates from the National Intellectual Property Administration [3]. Weekly Insights - The report suggests focusing on key players in the domestic AI computing power sector, such as Cambrian and Haiguang Information in chip design, and SMIC in advanced wafer manufacturing [4]. - The report also identifies various AI application companies across different sectors, including Kingsoft Office, Hehe Information, and Keda Xunfei in office automation and education [4]. Recent Developments - The report outlines significant investments and acquisitions in the AI sector, including Amazon's potential additional investment in Anthropic and Google's acquisition of AI programming startup Windsurf's core talent and technology [16][17]. - The report notes that xAI, led by Elon Musk, is negotiating a new funding round that could value the company at up to $200 billion, reflecting the growing interest and investment in AI technologies [10][18]. AI Application Ecosystem - The report highlights the rapid growth of AI applications, with OpenAI and Anthropic achieving annual recurring revenues (ARR) of $10 billion and $3 billion, respectively [22]. - Domestic AI applications like deepseek and Doubao are showing significant commercial potential, with user engagement metrics comparable to leading international AI applications [22]. Global AI Company Rankings - The report provides a ranking of global AI companies based on their ARR, with OpenAI leading at $10 billion, followed by Anthropic at $3.008 billion [23].

Group 1 - The internet insurance sector rose by 2.43%, ranking 8th among concept sectors, with 16 stocks increasing in value, including Jinzheng Co., which hit the daily limit, and Guoyuan Technology, Xinzhisoft, and Tianli Technology, which rose by 17.51%, 6.93%, and 5.59% respectively [1] - The sector saw a net inflow of 2.865 billion yuan, with 11 stocks receiving net inflows, and 5 stocks exceeding 100 million yuan in net inflows. Dongfang Caifu led with a net inflow of 1.592 billion yuan, followed by Jinzheng Co., China Ping An, and Xinhua Insurance with net inflows of 453 million yuan, 433 million yuan, and 199 million yuan respectively [2][3] Group 2 - In terms of capital inflow ratios, ST Yigou, Weining Health, and Jinzheng Co. had the highest net inflow ratios at 19.65%, 14.80%, and 14.64% respectively [3] - The internet insurance concept's capital inflow rankings showed Dongfang Caifu with a daily increase of 3.07% and a turnover rate of 8.21%, while Jinzheng Co. increased by 10.02% with a turnover rate of 16.10% [4]

Market Performance - As of July 11, the DRG/DIP concept increased by 2.41%, ranking 9th among concept sectors, with 22 stocks rising, including Jiahe Meikang, Weining Health, and Shanda Diwei, which rose by 5.89%, 5.58%, and 4.94% respectively [1] - The top-performing concept sectors today include Rare Earth Permanent Magnet at 5.64% and MLOps at 3.05%, while sectors like Housing Inspection and PCB saw declines of -1.47% and -1.17% respectively [2] Capital Flow - The DRG/DIP concept sector experienced a net inflow of 141 million yuan, with 11 stocks receiving net inflows, and 6 stocks seeing inflows exceeding 10 million yuan. Weining Health led with a net inflow of 190 million yuan, followed by Di'an Diagnosis, Shanda Diwei, and Donghua Software with net inflows of 25.57 million yuan, 20.81 million yuan, and 15.27 million yuan respectively [2] - In terms of capital inflow ratios, Weining Health, Shanda Diwei, and Di'an Diagnosis had the highest net inflow rates at 14.80%, 9.93%, and 7.13% respectively [3] Stock Performance - The top stocks in the DRG/DIP concept based on today's performance include: - Weining Health: 5.58% increase, 6.57% turnover rate, 189.87 million yuan net inflow, 14.80% net inflow ratio - Di'an Diagnosis: 2.23% increase, 4.75% turnover rate, 25.57 million yuan net inflow, 7.13% net inflow ratio - Shanda Diwei: 4.94% increase, 4.32% turnover rate, 20.81 million yuan net inflow, 9.93% net inflow ratio [3][4]

Group 1 - The core index of the CSI 1000 Information Technology Index is reported at 9130.36 points, with a one-month increase of 6.25%, a three-month increase of 11.71%, and a year-to-date increase of 7.69% [1] - The CSI 1000 Index series selects liquid and representative securities from each industry, forming 10 industry indices to provide diversified investment targets [1] - The top ten holdings of the CSI 1000 Information Technology Index include: O-film (2.69%), Huahong Semiconductor (1.54%), Heertai (1.42%), Siwei Tuxin (1.39%), Sifang Jichuang (1.33%), Jingfang Technology (1.27%), Chipone (1.25%), Weining Health (1.24%), Anji Technology (1.24%), and Tuobang Co. (1.2%) [1] Group 2 - The market share of the CSI 1000 Information Technology Index holdings is 57.12% from the Shenzhen Stock Exchange and 42.88% from the Shanghai Stock Exchange [1] - The industry composition of the index holdings includes: Software Development (24.50%), Integrated Circuits (19.58%), Optical Electronics (14.73%), IT Services (12.38%), Semiconductor Materials and Equipment (9.51%), Electronic Components (7.54%), Electronic Terminals and Components (7.10%), Other Electronics (2.08%), Electronic Chemicals (1.84%), and Discrete Devices (0.73%) [2] - The index sample is adjusted every six months, with adjustments implemented on the next trading day after the second Friday of June and December, and temporary adjustments may occur under special circumstances [2]

证券代码：300253 证券简称：卫宁健康 公告编号：2025-057 债券代码：123104 债券简称：卫宁转债 卫宁健康科技集团股份有限公司关于 预计触发卫宁转债转股价格向下修正条件的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 4、根据《卫宁健康科技集团股份有限公司向不特定对象发行可 转换公司债券募集说明书》（以下简称"《募集说明书》"）中相关规定， 在本次发行的可转换公司债券存续期间，当公司股票在任意连续三十 个交易日中至少有十五个交易日的收盘价低于当期转股价格的 85%时， 公司董事会有权提出转股价格向下修正方案并提交公司股东大会审 议表决。 截至本公告披露日，公司股票在 2025 年 6 月 30 日至 2025 年 7 月 11 日已有 10 个交易日的收盘价低于当期转股价格 17.31 元/股的 85%(即 14.71 元/股)，预计可能触发卫宁转债转股价格向下修正条件。 若触发转股价格向下修正条件，公司将于触发条件当日召开董事会审 议决定是否修正转股价格，并及时履行信息披露义务。敬请广大投资 者注意投资风险。 一、可 ...

最新一期业绩显示，2025年一季报，公司实现营业收入3.45亿元，同比-30.24%；净利润528.94万元，同 比-68.18%，销售毛利率34.46%。 7月8日，卫宁健康今日收盘10.01元，上涨1.32%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到289.29倍，总市值221.49亿元。 从行业市盈率排名来看，公司所处的软件开发行业市盈率平均120.22倍，行业中值86.10倍，卫宁健康排 名第175位。 截至2025年一季报，共有21家机构持仓卫宁健康，其中基金19家、其他2家，合计持股数29253.94万 股，持股市值31.59亿元。 卫宁健康科技集团股份有限公司的主营业务是集研发、销售和技术服务为一体，为客户提供"一体化"的 解决方案，致力于提供医疗健康卫生信息化解决方案。公司的主要产品是软件及服务、硬件销售、互联 网医疗健康。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13卫宁健康289.29252.003.74221.49亿行业平均 120.22139.869.05120.74亿行业中值86.1089.064.0057.30亿1理工能科17.6217.081.6 ...